Log In
BCIQ
Print this Print this
 

Mifedren (HRA 052015)

  Manage Alerts
Collapse Summary General Information
Company HRA Pharma S.A.
DescriptionCortisol blocking agent
Molecular Target Cortisol receptor GR-2
Mechanism of ActionCortisol receptor GR-2 antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II/III
Standard IndicationCushing's disease
Indication DetailsTreat ectopic Cushing's disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today